Richard Paling

BBI Diagnostics Group Ltd. develops and manufactures raw materials and finished test platforms for the in-vitro diagnostics market. The firm’s products include cell culture reagents, conjugates, depleted serum, disease state plasma, enzymes, finished kits, gold nanoparticles, monoclonal antibodies, normal serums, patient samples, polyclonal antibodies, recombinant antibodies, silver nanoparticles, biothreat and explosives antibodies. It’s services include custom conjugation, lateral flow assay development, 3DNA pushing assay sensitivity to the limit, test optimisation, atomo rapid platform and the novarum reader. The company was founded by John Chandler in 1986 and is headquartered in Cardiff, the United Kingdom.

Wolters Kluwer Health, Inc. provides professional information services for professionals and students in medicine, nursing, allied health, and pharmacy. It offers bibliographic and reference databases, drug information software, point-of-care tools, web-based information systems, and online education products. The company was founded on October 29, 2001 and is headquartered in Philadelphia, PA.

Exel Plc used to provide logistics services, including strategic management of the flow and storage of materials. It divided its logistics operations into two complementary segments, which included ground-based supply chain management services such as warehousing and distribution, assembly and just-in-time services. It also used to provide customer focused solutions to manufacturing and retail industries. The company was headquartered in Bracknell, UK

AstraZeneca Canada, Inc. develops and manufactures pharmaceutical drug preparations. Its therapeutic areas include cardiovascular and metabolic disease, oncology, and respiratory, inflammation and autoimmunity. The firm also active in the infection, neuroscience and gastrointestinal disease areas. The company was founded in 1999 and is headquartered in Mississauga, Canada.

Chroma Therapeutics Ltd. engages in the discovery and development of therapies for the treatment of cancer and inflammation. It focuses on the discovery and development of novel small molecule drugs based upon chromatin biology and novel cell accumulation approaches. The firm uses chromatin biology, drug accumulation approaches to discover and develop cancer, inflammation treatments and small molecule drugs. The company was founded by David Allis, Alan Hornsby Davidson, Alan Hastings Drummond, Anthony Kouzarides and Paul Workman in September 2001 and is headquartered in Abingdon, the United Kingdom.

Penn Pharmaceutical Services Ltd. provides drug development, clinical trial supply and pharmaceutical manufacturing services. Its services include solid oral and topical products formulation, pilot batches scale up and testing, clinical trials supplies manufacturing, process validation and technology transfer, formulation and analytical development, clinical trial packing and labeling, and storage and distribution. The company was founded in 1977 and is headquartered in Tredegar, the United Kingdom.

Idis Ltd. supplies pharmaceuticals and allied services to the healthcare industry. the company was founded by Crane Michael and Gould Amanda in 1987 and is headquartered in Weybridge, The united kingdom

Great Point Partners Private Equity (Great Point Partners) is a private equity subsidiary of Great Point Partners LLC founded in 2003 by Jeffrey Robert Jay and David Eric Kroin. The firm is headquartered in Greenwich, Connecticut.

Celentyx Ltd. provides research and development on human immune disease. The firm's services include rapid analysis screening of drug action on physiological and pathological human immune tissues and cells. It provides services by disease, cell type, assay through its ImmuKnowlogy platform technology. The company was founded by Nicholas Mark Barnes and John Gordon in 2004 and is headquartered in Birmingham, the United Kingdom.

Spark Therapeutics Ireland Ltd. develops new gene medicines to treat autosomal dominant genetic diseases. Its product RhoNova, is designed for the treatment of patients with rhodopsin linked autosomal dominant retinitis pigmentosa, a debilitating, progressive form of inherited blindness resulting from a diverse array of mutations in the RHO gene. The company was founded by Jane G. Farrar, Paul Kenna, and Gearóid Tuohy and is headquartered in Dublin, Ireland.

London Stock Exchange Plc, operates as a stock exchange. It offers capital market, trading, information, derivatives, studio, regulatory, enhanced, connectivity, telephone network, reference and historical data, historic price, corporate action, trade data, valuation data, broker ranking, matching and reconciliation. The company was founded in 1571 and is headquartered in London, the United Kingdom.

Zeneca Pharmaceuticals manufactures medicines.

Kymab Ltd. discovers and develops human monoclonal antibody drugs. It is using mouse embryonic stem cell technology to develop its Kymouse platform that focuses on encompassing the diversity of the B lymphocyte component of the human immune system, and has the potential for expansion of diversity beyond the normal human immune response. Kymab was founded by Allan Bradley in 2009 and is headquartered in Cambridge, the United Kingdom.

Sustrans Ltd. operates as a charity that provides travel choices. It connects people and places, liveable neighbourhoods, transform the school run and delivers commute. The company was founded in 1977 and is headquartered in Bristol, the United Kingdom.

Macrotarg Ltd. is a biotechnology research and British experimental development company founded in 2007. The private company is based in Winnersh, UK.

Mitre Group Ltd. provides sports and stadia training services. The firm consults on providing apprenticeships, staff development courses and pre-employment programmes. It offers coach education, sports development, youth work, stadia safety, management and leadership, customer service, employability skills, health and safety and first aid. The company is headquartered in Derby, the United Kingdom.

BBI Diagnostics Group 2 Plc provides diagnostic tests and materials. It offers a portfolio of products and services that are provided to the diagnostic, healthcare, research, defense, and food industries. The company was founded on October 22, 2013 and is headquartered in Bedford, the United Kingdom.

Part of Triley Bidco Ltd., Clinigen CTS Ltd. is a British company that provides investigator-initiated studies services to investigators, with managed regulatory pathways required for support of IIS & EAP programs. The company is based in Burton-On-Trent, UK and has more than 30 years ’ experience providing quicker and broader access to critical medicines in 130+ countries, pre- and post-launch. The company helps Pharmaceutical and Biotech companies grant access to unlicensed medicines around the globe. Clinigen's controlled drug handling services include five DEA registrations: manufacturer, importer, exporter, distributor, and retail pharmacy services. The company also offers a Patient Advocate Fellowship.

Part of Triley Bidco Ltd., Clinigen Healthcare Ltd. is a British company founded in 2007 that has more than 30 years of experience providing quicker and broader access to critical medicines in 130+ countries, pre- and post-launch. The company is based in Burton-on-Trent, UK. The company's investigator-initiated studies services provide smart solutions to investigators, with managed regulatory pathways required for support of IIS & EAP programs. Through the Clinigen Management Access, patient and healthcare professionals are granted access to the medicines they need.

Keats Healthcare Ltd. engages in manufacturing and processing of drugs in pharmaceutical preparations for human or veterinary use. The company was founded on May 15, 2008 and is headquartered in Burton-On-Trent, the United Kingdom.

Part of Iovance Biotherapeutics, Inc., Clinigen SP Ltd. is a British pharmaceutical company that manufactures and sells pharmaceutical products. The company is based in Burton-On-Trent, UK. The company was founded in 2013. Clinigen was acquired by Iovance Biotherapeutics, Inc. from Clinigen Holdings Ltd. on May 18, 2023 for $264.04 million.

Linear Diagnostics Ltd. operates as a diagnostics company based on a novel technology that allows wide range of molecular diagnostics tests to be carried out using a simple optical system. It specializes in molecular diagnostics, novel technology and optical detection. The company was founded by Matt Hicks in 2011 and is headquartered in Birmingham, the United Kingdom.

Oxford Quantum Circuits Ltd. engages in quantum research. Its research includes research stories, major themes, and impacts. The company was founded by Peter James Leek on June 5, 2017 and is headquartered in Oxford, the United Kingdom.

DRI Healthcare Plc is a closed-ended investment company, which invests in a portfolio of cash flow generating healthcare royalty assets. The company was founded on December 13, 2019 and is headquartered in London, the United Kingdom.

Part of Triley Bidco Ltd., Clinigen Holdings Ltd. develops pharmaceutical products. The company is based in Burton-on-Trent, UK. Clinigen Holdings was founded in 2017.

Transine Therapeutics Ltd. is an RNA platform company based in Cambridge, UK. The British company is developing a novel class of therapeutic RNAs called SINEUPs, which can upregulate protein expression with a superior level of control and specificity across an unprecedented range of diseases and applications. The company's proprietary technology allows them to address diseases that have been beyond the reach of small molecules, conventional biologics, or gene therapies. The SINEUP platform boosts the expression of almost any chosen target protein by binding precisely to the mRNA that encodes it and enhancing its translation. This technology massively extends the druggable proteome and represents an entirely new mechanism of action, ideally suited to address currently hard-to-treat diseases. The company was founded in 2018 by Stefano Gustincich and Piero Carninci. Jan Thirkettle has been the CEO of the company since 2021.

Triley Bidco Ltd. is an investment holding British company founded in 2021. The private company is based in London, UK. and has a global presence of subsidiaries in several regions. Triley Bidco functions as an investment holding company.

Part of Triley Bidco Ltd., Idis Group Holdings Ltd. is a holding British company. The company is based in Burton-on-Trent, UK. Founded in 2005, Idis Group Holdings operates as a holding company.

Part of Triley Bidco Ltd., Idis Group Ltd. functions as an investment holding British company. The company is based in Burton-On-Trent, UK.